Showing results (281-290 of 781) with videos related to
Sort By:
Pageof 79
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 22, 2025
Advances in RNA therapeutics and its delivery strategies against Multiple MyelomaKaiwen Luo, Zhongkun Zhang, Siyu Yao, et al.Blood|February 25, 2016
MUC1-C drives MYC in multiple myelomaAshujit Tagde, Hasan Rajabi, Audrey Bouillez, et al.Blood Advances|October 15, 2021
Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISHYuting Yan, Xiaoqi Qin, Jiahui Liu, et al.Blood|March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myelomaYan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.Blood Advances|November 8, 2019
Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myelomaAndrea Schmidts, Maria Ormhøj, Bryan D Choi, et al.Blood|October 2, 2007
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieuYu-Tzu Tai, Myles Dillon, Weihua Song, et al.Hematology. American Society of Hematology. Education Program|November 26, 2002
Multiple myelomaKenneth C Anderson, John D Shaughnessy, Bart Barlogie, et al.Hematology/Oncology Clinics of North America|September 13, 2014
Novel targeted agents in the treatment of multiple myelomaCindy Varga, Jacob Laubach, Teru Hideshima, et al.Nature Communications|May 2, 2018
Widespread intronic polyadenylation diversifies immune cell transcriptomesIrtisha Singh, Shih-Han Lee, Adam S Sperling, et al.British Journal of Haematology|July 23, 2011
Monoclonal antibodies in the treatment of multiple myelomaPaul G Richardson, Sagar Lonial, Andrzej J Jakubowiak, et al.Pageof 79